ProQR Therapeutics (PRQR) Net Margin (2021 - 2025)
Historic Net Margin for ProQR Therapeutics (PRQR) over the last 5 years, with Q3 2025 value amounting to 382.69%.
- ProQR Therapeutics' Net Margin fell 1618900.0% to 382.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 283.23%, marking a year-over-year decrease of 1498500.0%. This contributed to the annual value of 146.86% for FY2024, which is 2848100.0% up from last year.
- According to the latest figures from Q3 2025, ProQR Therapeutics' Net Margin is 382.69%, which was down 1618900.0% from 336.94% recorded in Q2 2025.
- In the past 5 years, ProQR Therapeutics' Net Margin ranged from a high of 42.7% in Q2 2024 and a low of 8941.13% during Q1 2021
- Moreover, its 5-year median value for Net Margin was 663.32% (2023), whereas its average is 1921.78%.
- Data for ProQR Therapeutics' Net Margin shows a peak YoY increase of 76925500bps (in 2022) and a maximum YoY decrease of -11390500bps (in 2022) over the last 5 years.
- ProQR Therapeutics' Net Margin (Quarter) stood at 7623.85% in 2021, then soared by 76bps to 1846.81% in 2022, then surged by 92bps to 150.3% in 2023, then plummeted by -42bps to 213.7% in 2024, then crashed by -79bps to 382.69% in 2025.
- Its last three reported values are 382.69% in Q3 2025, 336.94% for Q2 2025, and 231.25% during Q1 2025.